Evolv Q1 2025 Earnings Report
Key Takeaways
Evolv Technology reported strong first quarter 2025 results, with revenue increasing 44% year-over-year to $32.0 million and Annual Recurring Revenue (ARR) reaching $106.0 million, up 34%. The company significantly reduced its net loss to $(1.7) million and achieved positive Adjusted EBITDA of $1.7 million.
Total revenue for Q1 2025 was $32.0 million, a 44% increase compared to Q1 2024.
Ending Annual Recurring Revenue (ARR) was $106.0 million as of March 31, 2025, up 34% year-over-year.
Net loss for Q1 2025 was $(1.7) million, a significant improvement from $(11.3) million in Q1 2024.
Adjusted EBITDA for Q1 2025 was positive at $1.7 million, compared to $(10.4) million in Q1 2024.
Evolv
Evolv
Evolv Revenue by Segment
Forward Guidance
For the full year 2025, Evolv Technology expects total revenues to be between $125 to $130 million, representing 20% to 25% growth over 2024. The company anticipates achieving positive full year Adjusted EBITDA with low to mid-single digit margins and expects positive free cash flow in the fourth quarter of 2025.
Positive Outlook
- Expected revenue growth of 20%-25% in 2025.
- Anticipates positive full year Adjusted EBITDA.
- Forecasts Adjusted EBITDA margins in the low to mid-single digits for the full year.
- Expects to achieve positive free cash flow in the fourth quarter of 2025.
- Focus on operational efficiency to drive improved profitability and cash flow.
Challenges Ahead
- Plans near-term investments of approximately $2 million in 2025 which will impact profitability in the short term.
- Outlook is based on current indications and may change.
- Unable to provide a reconciliation of forward-looking Adjusted EBITDA to Net Income (Loss) due to unpredictable items.
- Forward-looking statements are not guarantees of future performance.
- Actual future results may differ materially from expectations.
Revenue & Expenses
Visualization of income flow from segment revenue to net income